Stage IV Mycosis Fungoides/Sezary Syndrome Completed Phase 1 / 2 Trials for Ifosfamide (DB01181)

IndicationStatusPhase
DBCOND0028720 (Stage IV Mycosis Fungoides/Sezary Syndrome)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00601718Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaTreatment